Over the last year, the dangerous severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) has spread rapidly around the world. Malaysia has not been excluded from this …

Background Malaysia's public healthcare sector provides a greater volume of medicines at
lower overall cost compared to the private sector, indicating its importance in providing …

Medicine price directly affects affordability and access to medicines particularly in countries
where a major portion of pharmaceutical spending is through out-of-pocket payment, such …

Background The lack of price control in Malaysia has led to increased market competition,
resulting in high medicine prices, notably in the private sector. This largely affects patients' …

Escalating costs have made the accessibility of drugs one of the biggest challenges faced by
the Malaysian government. The government agreed to regulate drug prices by means of …

Objective To describe the process and role of health technology assessment (HTA) in the
context of drug policy in Malaysia. Methods We summarized the HTA process through …

Background As part of the initiatives to increase price transparency for consumers,
pharmaceutical industry in Malaysia have been encouraged to declare the wholesale and …

External price referencing (EPR) describes a policy to set medicine prices based on price
data of the same medicine in other countries. The aim of this chapter is to present how EPR …

Background: Medicine price transparency refers to the practice of making prices available to
consumers for them to identify, compare, and select the medicine that provides the desired …

This study aims to assess the opinion of community pharmacists regarding the zoning of
community pharmacies in Malaysia. A semistructured qualitative study utilizing face-to-face …